What Are the Top 5 Mistakes Foreign Investors Make in France?
⸻
France remains one of the most attractive destinations for foreign investment in Europe.
It offers:
• a large domestic market
• strong industrial capabilities
• access to the European Union
• a sophisticated regulatory environment
Yet, in cross-border M&A and strategic investments, a recurring pattern emerges:
Deals do not fail because of market fundamentals.
They fail because foreign investors misunderstand how France works.
More specifically, they underestimate the role of the State, the importance of regulatory perception, and the strategic dimension of transactions.
This article identifies the five most common mistakes foreign investors make in France—and how to avoid them.
⸻
Mistake #1: Treating France Like Any Other Market
The first mistake is conceptual.
Many investors approach France as they would:
• the UK
• the US
• other European jurisdictions
This is a structural error.
France operates under a distinct model where:
• the State plays an active role
• economic sovereignty is a core principle
• regulatory frameworks are deeply embedded in transaction dynamics
As a result:
A deal that works elsewhere may fail in France.
Not because it is flawed.
But because it is not aligned with institutional expectations.
⸻
Mistake #2: Underestimating FDI Screening Risk
One of the most critical errors is underestimating foreign investment control.
Many investors assume that:
• only defense deals are concerned
• only large acquisitions trigger review
• regulatory approval is a formality
All three assumptions are incorrect.
In reality:
• sensitive sectors are broad and expanding
• minority investments can be reviewed
• approval is not guaranteed
Failing to anticipate this leads to:
• unexpected delays
• deal restructuring
• in some cases, transaction failure
FDI screening is not a legal detail.
It is a core execution variable.
⸻
Mistake #3: Focusing Only on Legal and Financial Structuring
Foreign investors often rely heavily on:
• legal advisors
• financial modeling
• tax optimization
While essential, these elements are not sufficient in France.
Why?
Because transactions are also assessed based on:
• strategic impact
• industrial logic
• alignment with national interests
A deal can be:
• perfectly structured legally
• financially sound
And still face resistance.
This creates a gap between:
What is technically valid
And what is institutionally acceptable
⸻
Mistake #4: Ignoring the Importance of Narrative
In France, how a transaction is presented matters.
Authorities evaluate not only:
• what the deal is
• but what it means
A weak narrative creates:
• uncertainty
• additional scrutiny
• regulatory friction
Typical issues include:
• unclear strategic rationale
• lack of long-term commitment
• perceived risk to national capabilities
Conversely, a strong narrative can:
• facilitate approval
• build trust
• reduce resistance
This dimension is systematically underestimated by foreign investors.
⸻
Mistake #5: Reacting Too Late to State Risk
The most damaging mistake is timing.
Many investors only address State-related risks:
• after signing
• during the approval phase
• when issues arise
At that stage, options are limited.
This leads to:
• delays
• renegotiation
• loss of control over the process
In some cases, the transaction becomes impossible to execute.
State risk must be addressed:
before the deal is structured
before a binding offer is submitted
Anything later is reactive—and therefore risky.
⸻
The Common Pattern Behind These Mistakes
These five mistakes share a common root:
A compliance-driven mindset.
Foreign investors tend to view France through a legal lens:
• What are the rules?
• What is required?
But the real question is different:
How will the State perceive this transaction?
This shift—from compliance to perception—is critical.
⸻
The Real Risk: Losing Control of Execution
When these mistakes accumulate, investors lose control over:
• the timeline
• the approval process
• the outcome of the deal
This creates a structural execution risk.
In competitive M&A environments, this has immediate consequences:
• weaker bids
• reduced credibility
• lower probability of success
Execution—not structuring—is the decisive factor.
⸻
What Successful Investors Do Differently
Investors who succeed in France adopt a different approach.
They:
• anticipate regulatory exposure early
• integrate State risk into deal strategy
• align transactions with institutional expectations
• control the narrative
• manage the approval process proactively
This approach transforms risk into a manageable variable.
⸻
From Mistakes to Strategy
Avoiding mistakes is not enough.
The objective is to build a strategy that:
• identifies risks upfront
• structures the deal accordingly
• anticipates regulatory expectations
• secures approval
This requires a different mindset:
From reactive to proactive
From legal to strategic
From compliance to execution
⸻
Relians Perspective: Bridging the Gap
The gap between foreign investors and the French system is not a knowledge gap.
It is a strategic gap.
Understanding the rules is not sufficient.
What matters is:
• anticipating how decisions are made
• aligning the transaction with State priorities
• managing institutional dynamics
This is where most investors fail.
And where transactions are won or lost.
⸻
Why This Matters Before You Invest
Entering the French market without addressing these issues exposes investors to:
• regulatory uncertainty
• execution delays
• reputational risk
• potential deal failure
Conversely, anticipating these factors allows investors to:
• secure their position
• strengthen their bids
• control timelines
• increase approval probability
⸻
France Rewards Prepared Investors
France is not a difficult market.
It is a structured one.
Foreign investors who approach it with:
• the right framework
• the right timing
• the right strategy
can execute transactions successfully.
Those who rely on standard approaches often encounter friction.
The difference lies in anticipation.
⸻
From Common Mistakes to Controlled Execution
Most foreign investors only realize these mistakes when the transaction is already at risk.
At that stage:
• timelines are slipping
• regulatory uncertainty increases
• negotiation leverage decreases
The issue is not identifying the mistake.
It is correcting it under time pressure.
In France, this is rarely effective.
What changes the outcome is not expertise alone—but timing and positioning.
The ability to anticipate, rather than react.
⸻
Relians Diagnostic: Identify Your Exposure Before It Becomes a Risk
Before entering a transaction, the key question is not:
“Is there a risk?”
But:
“Where exactly is the risk—and how will it impact execution?”
Relians has developed a diagnostic approach specifically designed for foreign investors operating in France.
This assessment allows you to:
• identify whether your transaction is exposed to FDI screening or State intervention
• detect hidden risk factors linked to your investor profile, structure, or target
• evaluate your level of exposure to regulatory and institutional scrutiny
• anticipate potential delays or objections
• define a clear execution strategy
This is not a legal checklist.
It is a strategic tool designed to secure your deal.
⸻
Why This Step Is Critical in Competitive Transactions
In competitive M&A processes, the difference is rarely price.
It is execution certainty.
Investors who anticipate State risk early can:
• move faster
• structure better
• present a more credible offer
• secure approval under controlled conditions
Those who do not remain exposed to the exact mistakes outlined above.
⸻
Move From Risk Exposure to Execution Control
If you are considering an acquisition in France, waiting is a risk.
Understanding your exposure early is a strategic advantage.
A structured diagnostic allows you to move from uncertainty to control—and from risk to execution.
⸻
FAQ: Foreign Investment in France
Is France open to foreign investors?
Yes, but transactions in sensitive sectors are subject to review and must align with national interests.
What is the biggest mistake foreign investors make?
Underestimating the role of the State and treating regulatory approval as a formality.
Can minority investments be reviewed?
Yes, especially if they grant influence or access to sensitive assets.
When should regulatory risk be assessed?
Before structuring the deal or submitting a binding offer.
How can investors improve their chances of success?
By anticipating risks early, aligning the transaction with institutional expectations, and managing the process strategically.
⸻
